In vitro assessment of human nuclear hormone receptor activity and cytotoxicity of the flame retardant mixture FM 550 and its triarylphosphate and brominated components

被引:93
作者
Belcher, Scott M. [1 ]
Cookman, Clifford J. [1 ]
Patisaul, Heather B. [2 ]
Stapleton, Heather M. [3 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA
[2] N Carolina State Univ, Dept Biol Sci, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA
[3] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA
关键词
Apoptosis Endocrine disruptor; Flame retardant; Nuclear receptors; Obesity; Peroxisome proliferator-activated receptor; METABOLIC SYNDROME; ORGANOTIN COMPOUNDS; PROTEIN-KINASE; ADIPOGENESIS; OBESITY; ACTIVATION; CHEMICALS; TOXICITY; NEURONS;
D O I
10.1016/j.toxlet.2014.04.017
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Firemaster 550 (FM 550) is a mixture of brominated and triarylphosphate flame retardants used in polyurethane foam-based products. The primary components are also used in numerous other applications and are thus common household and industrial contaminants. Our previous animal studies suggested that FM 550 exposure may alter metabolism and cause weight gain. Employing human nuclear receptor (NR) luciferase reporter assays, the goal of this study was to evaluate the agonist actions of FM 550 and its constituent compounds at NRs with known roles in establishing or regulating energy balance. FM 550 was found to have significant agonist activity only at the master regulator of adipocyte differentiation PPAR-y. As a result, the concentration response relationships and relative activities of FM 550 at PPAR-y were investigated in more detail with the contribution of each chemical component defined and compared to the activities of the prototypical PPAR-y environmental ligands triphenyltin and tributyltin. The resulting data indicated that the primary metabolic disruptive effects of FM 550 were likely mediated by the activity of the triarylphosphates at PPAR-y, and have identified TPP as a candidate metabolic disruptor that also acts as a cytotoxicant. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 31 条
[1]   Blockade of Estrogen Receptor Signaling Inhibits Growth and Migration of Medulloblastoma [J].
Belcher, Scott M. ;
Ma, Xiaolan ;
Le, Hoa H. .
ENDOCRINOLOGY, 2009, 150 (03) :1112-1121
[2]   Rapid estrogenic regulation of extracellular signal-regulated kinase 1/2 signaling in cerebellar granule cells involves a G protein- and protein kinase A-dependent mechanism and intracellular activation of protein phosphatase 2A [J].
Belcher, SM ;
Le, HH ;
Spurling, L ;
Wong, JK .
ENDOCRINOLOGY, 2005, 146 (12) :5397-5406
[3]   Analysis of the flame retardant metabolites bis(1,3-dichloro-2-propyl) phosphate (BDCPP) and diphenyl phosphate (DPP) in urine using liquid chromatography-tandem mass spectrometry [J].
Cooper, E. M. ;
Covaci, A. ;
van Nuijs, A. L. N. ;
Webster, T. F. ;
Stapleton, H. M. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2011, 401 (07) :2123-2132
[4]   The ToxCast program for prioritizing toxicity testing of environmental chemicals [J].
Dix, David J. ;
Houck, Keith A. ;
Martin, Matthew T. ;
Richard, Ann M. ;
Setzer, R. Woodrow ;
Kavlock, Robert J. .
TOXICOLOGICAL SCIENCES, 2007, 95 (01) :5-12
[5]   Minireview: The Case for Obesogens [J].
Gruen, Felix ;
Blumberg, Bruce .
MOLECULAR ENDOCRINOLOGY, 2009, 23 (08) :1127-1134
[6]   Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates [J].
Grun, Felix ;
Watanabe, Hajime ;
Zamanian, Zamaneh ;
Maeda, Lauren ;
Arima, Kayo ;
Chubacha, Ryan ;
Gardiner, David M. ;
Kanno, Jun ;
Iguchi, Taisen ;
Blumberg, Bruce .
MOLECULAR ENDOCRINOLOGY, 2006, 20 (09) :2141-2155
[7]   Structure-dependent activation of peroxisome proliferator-activated receptor (PPAR) γ by organotin compounds [J].
Hiromori, Youhei ;
Nishikawa, Jun-ichi ;
Yoshida, Ichiro ;
Nagase, Hisamitsu ;
Nakanishi, Tsuyoshi .
CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 180 (02) :238-244
[8]   Effects of triaryl phosphate's on mouse and human nuclear receptors [J].
Honkakoski, P ;
Palvimo, JJ ;
Penttilä, L ;
Vepsäläinen, J ;
Auriola, S .
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (01) :97-106
[9]   Developmental effects: oestrogen-induced vaginal changes and organotin-induced adipogenesis [J].
Iguchi, T. ;
Watanabe, H. ;
Ohta, Y. ;
Blumberg, B. .
INTERNATIONAL JOURNAL OF ANDROLOGY, 2008, 31 (02) :263-268
[10]   Metabolic programming: fetal origins of obesity and metabolic syndrome in the adult [J].
Ismail-Beigi, Faramarz ;
Catalano, Patrick M. ;
Hanson, Richard W. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2006, 291 (03) :E439-E440